Cannabis Strategic Ventures NUGS

Stock OTCM Rating as of Oct 23, 2026

$0.01 0.00 (23.40%)

As of Oct 23, 2026, 7:55:06 PM Delayed Price Closed

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

View History

NUGS is trading at a LOCK|^Y<^j% premium.

Price

$0.01

Oct 23, 2026

Fair Value

LOCK|cl%<H^@

Oct 17, 2026

Uncertainty

LOCK|D^ @!ZnG

1-Star Price: LOCK|f%x!!hK
5-Star Price: LOCK|sB$<^<Q
Economic Moat: LOCK|gdn@n
Capital Allocation: —

Trading Information

Previous Close Price: $0.00
Day Range: $0.00–0.01
52-Week Range: $0.00–0.09
Bid/Ask: $0.00 / $0.01
Shares Outstanding: 402.29M
Market Cap: $2.14M
Volume/Avg: 39,286 / 2M

Key Statistics

Price/Earnings (Normalized): —
Price/Sales: —
Dividend Yield (Trailing): 0.00%
Dividend Yield (Forward): 0.00%
Dividend Payment Schedule: —
Total Yield: —

Company Profile

Cannabis Strategic Ventures had no active business operations.

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Stock Style Box: —
Total Number of Employees: —
Website: —

Valuation

Metric	NUGS
Price/Earnings (Normalized)	—
Price/Book Value	—
Price/Sales	—
Price/Cash Flow	—

Price/Earnings

No chart available

Financial Strength

Metric	NUGS
Quick Ratio	0.09
Current Ratio	0.27
Interest Coverage	−163.31

Quick Ratio

NUGS

Profitability

Metric	NUGS
Return on Assets (Normalized)	−45.08%
Return on Equity (Normalized)	—
Return on Invested Capital (Normalized)	−50.51%

Return on Assets

NUGS

Drug Manufacturers - Specialty & Generic Industry Comparables

Screen With Investor

Name	Capital Allocation	Economic Moat	Market Cap
Merck KGaA ADR MKKGY	LOCK\|L#BRWVV	LOCK\|FtGWN	$70B
Teva Pharmaceutical Industries Ltd TEVA	LOCK\|$TR%RJy%	LOCK\|%WbT^	$46B
Haleon PLC ADR HLN	LOCK\|C%n$G!	LOCK\|G>	$45B
Zoetis Inc Class A ZTS	LOCK\|jpP$fwp	LOCK\|>Yf	$33B
Viatris Inc VTRS	LOCK\|g!R#GcH	LOCK\|Wl<	$21B
Elanco Animal Health Inc ELAN	LOCK\|W<	LOCK\|Vd<	$11B
Dr Reddy's Laboratories Ltd ADR RDY	LOCK\|nZ$tkRD	LOCK\|DVB	$11B
Hims & Hers Health Inc Ordinary Shares - Class A HIMS	LOCK\|Vhq>S@	LOCK\|DQ	$6B
Prestige Consumer Healthcare Inc PBH	LOCK\|Z%^>@hT	LOCK\|q$$#t	$2B
Perrigo Co PLC PRGO	LOCK\|X?zB?D	LOCK\|H#	$2B